Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients
who are immunocompromised or seriously ill. The major pathogens include those of the …

Infections caused by the fungal pathogen Aspergillus fumigatus are increasingly resistant to
first-line azole antifungal drugs. However, despite its clinical importance, little is known …

Pulmonary cryptococcosis describes an invasive lung mycosis caused by Cryptococcus
neoformans or Cryptococcus gattii complex. It is often a high-consequence disease in both …

Rezafungin (formerly CD101) is a new β-glucan synthase inhibitor that is chemically related
with anidulafungin. It is considered the first molecule of the new generation of long-acting …

Although not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility
testing (AFST) is a tool of increasing importance in clinical microbiology laboratories. The …

Aims Candida albicans is an important opportunistic pathogen, responsible for the majority
of yeast infections in humans. Essential oils, extracted from aromatic plants, are well‐known …

The incidence of candidemia by the Candida parapsilosis complex has increased
considerably in recent decades, frequently related to use of indwelling intravascular …

New data from the years 2012 to 2015 from the Danish National Fungemia Surveillance are
reported, and epidemiological trends are investigated in a 12-year perspective (2004 to …

We have been monitoring the antifungal resistance in Candida parapsilosis isolates
collected from inpatients at Madrid metropolitan area hospitals for the last 3 years. The study …